Product Details
CinnoRA Injection (Adalimumab) 40mg/0.8ml In Pakistan
CinnoRA Injection contains Adalimumab 40mg/0.8ml, a prescription biologic medicine known as a TNF inhibitor. It is used under medical supervision for certain inflammatory and autoimmune conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, psoriasis, and other approved conditions depending on the patient's age and medical history.
CinnoRA works by blocking TNF (tumor necrosis factor), a substance involved in inflammation. It can help reduce inflammation and symptoms associated with certain chronic inflammatory diseases. It should only be used according to a qualified healthcare professional’s prescription.
Benefits
- Contains Adalimumab 40mg/0.8ml
- Helps reduce inflammation associated with certain autoimmune conditions
- TNF inhibitor biologic therapy
- Used for several approved inflammatory conditions
- May help improve disease-related symptoms and daily functioning in appropriate patients
- Suitable for long-term treatment only when prescribed and monitored by a healthcare professional
How to Use
- CinnoRA should be used only as prescribed by your doctor.
- It is administered by subcutaneous injection, usually into the abdomen or thigh.
- Your doctor or healthcare professional will determine the correct dose and injection schedule according to your condition.
- Follow the prescribed schedule carefully and do not change the dose yourself.
- Before using, check the medicine's packaging, expiry date, and appearance according to the manufacturer's instructions.
- If you miss a dose, contact your doctor or pharmacist for advice rather than taking an extra dose.
- Do not share the injection with another person.
Why Choose CinnoRA?
- Contains the established biologic medicine Adalimumab
- Convenient 40mg/0.8ml pre-measured strength
- Used in the management of several approved inflammatory conditions
- Provides targeted TNF inhibition
- Should be used with appropriate medical supervision and regular follow-up
Important Safety Information
Adalimumab can increase the risk of serious infections and may not be appropriate for people with certain infections or medical conditions. Before starting treatment, your healthcare professional may check for conditions such as tuberculosis (TB) and hepatitis. Tell your doctor about your medical history and all medicines you take.
Seek medical advice promptly if you develop signs of a serious infection, severe allergic reaction, or other concerning symptoms. CinnoRA is a prescription medicine and should be used only under the supervision of a qualified healthcare professional.
